IRIDEX ($IRIX) is expected to release its quarterly earnings data on Thursday, March 27th after market close, per Finnhub. Analysts are expecting revenue of $13,464,000 and earnings of -$0.06 per share.
You can see Quiver Quantitative's $IRIX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IRIDEX Hedge Fund Activity
We have seen 5 institutional investors add shares of IRIDEX stock to their portfolio, and 15 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LONG FOCUS CAPITAL MANAGEMENT, LLC removed 61,827 shares (-61.8%) from their portfolio in Q4 2024, for an estimated $103,869
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 34,524 shares (-52.8%) from their portfolio in Q4 2024, for an estimated $58,000
- CITADEL ADVISORS LLC added 17,377 shares (+34.6%) to their portfolio in Q4 2024, for an estimated $29,193
- RENAISSANCE TECHNOLOGIES LLC removed 16,200 shares (-4.1%) from their portfolio in Q4 2024, for an estimated $27,216
- TRUIST FINANCIAL CORP added 12,979 shares (+inf%) to their portfolio in Q4 2024, for an estimated $21,804
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 6,975 shares (-9.1%) from their portfolio in Q4 2024, for an estimated $11,718
- UBS GROUP AG removed 3,586 shares (-22.6%) from their portfolio in Q4 2024, for an estimated $6,024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
IRIDEX Government Contracts
We have seen $91,290 of award payments to $IRIX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- 4566609426!OCULIGHT TX: $22,594
- 4565945528!SLIT LAMP AND MOTORIZED TABLE: $19,800
- HAMPTON VAMC IRIDEX OPHTHALMIC LASER MAINTENANCE. BASE PLUS TWO.: $12,942
- IRIDEX LASER REPAIR; OPS DIODE REPLACEMENT.: $12,483
- 4565542569!IR TRUFOCUS LIO+: $11,220
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
